Found: 31
Select item for more details and to access through your institution.
Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model.
- Published in:
- Annals of the New York Academy of Sciences, 2019, v. 1442, n. 1, p. 91, doi. 10.1111/nyas.13991
- By:
- Publication type:
- Article
Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anabolic Strategies to Augment Bone Fracture Healing.
- Published in:
- Current Osteoporosis Reports, 2018, v. 16, n. 3, p. 289, doi. 10.1007/s11914-018-0440-1
- By:
- Publication type:
- Article
Projections from the Rostral Zona Incerta to the Thalamic Paraventricular Nucleus Mediate Nociceptive Neurotransmission in Mice.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 2, p. 226, doi. 10.3390/metabo13020226
- By:
- Publication type:
- Article
Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 4, p. 865, doi. 10.1002/jbmr.1807
- By:
- Publication type:
- Article
Inhibition of Sclerostin by Monoclonal Antibody Increases Bone Formation, Bone Mass, and Bone Strength in Aged Male Rats.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 12, p. 2371, doi. 10.1002/jbmr.182
- By:
- Publication type:
- Article
Sclerostin Antibody Treatment Enhances Metaphyseal Bone Healing in Rats.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 11, p. 2412, doi. 10.1002/jbmr.135
- By:
- Publication type:
- Article
Dramatic Increase in Cortical Thickness Induced by Femoral Marrow Ablation Followed by a 3-Month Treatment with PTH in Rats.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 6, p. 1350, doi. 10.1002/jbmr.25
- By:
- Publication type:
- Article
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 4, p. 578, doi. 10.1359/jbmr.081206
- By:
- Publication type:
- Article
A Nonprostanoid EP4 Receptor Selective Prostaglandin E<sub>2</sub> Agonist Restores Bone Mass and Strength in Aged, Ovariectomized Rats.
- Published in:
- Journal of Bone & Mineral Research, 2006, v. 21, n. 4, p. 565, doi. 10.1359/jbmr.051110
- By:
- Publication type:
- Article
A New Vitamin D Analog, 2MD, Restores Trabecular and Cortical Bone Mass and Strength in Ovariectomized Rats With Established Osteopenia.
- Published in:
- Journal of Bone & Mineral Research, 2005, v. 20, n. 10, p. 1742, doi. 10.1359/JBMR.050605
- By:
- Publication type:
- Article
A Novel, Non-Prostanoid EP2 Receptor-Selective Prostaglandin E<sub>2</sub> Agonist Stimulates Local Bone Formation and Enhances Fracture Healing.
- Published in:
- Journal of Bone & Mineral Research, 2003, v. 18, n. 11, p. 2033, doi. 10.1359/jbmr.2003.18.11.2033
- By:
- Publication type:
- Article
Lasofoxifene (CP-336,156) Protects Against the Age-Related Changes in Bone Mass, Bone Strength, and Total Serum Cholesterol in Intact Aged Male Rats.
- Published in:
- Journal of Bone & Mineral Research, 2001, v. 16, n. 4, p. 765, doi. 10.1359/jbmr.2001.16.4.765
- By:
- Publication type:
- Article
Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) and Risedronate Was Superior to PGE<sub>2</sub> Alone in Maintaining Newly Added Bone in the Cortical Bone Site After Withdrawal in Older Intact Rats.
- Published in:
- Journal of Bone & Mineral Research, 1997, v. 12, n. 2, p. 267, doi. 10.1359/jbmr.1997.12.2.267
- By:
- Publication type:
- Article
Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 11, p. 1726, doi. 10.1002/jbmr.5650101116
- By:
- Publication type:
- Article
Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: A dual-energy X-ray absorptiometric and histomorphometric study.
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 8, p. 1256, doi. 10.1002/jbmr.5650100816
- By:
- Publication type:
- Article
Extra cancellous bone induced by combined prostaglandin E<sub>2</sub> and risedronate administration is maintained after their withdrawal in older female rats.
- Published in:
- Journal of Bone & Mineral Research, 1995, v. 10, n. 6, p. 963, doi. 10.1002/jbmr.5650100618
- By:
- Publication type:
- Article
Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
- Published in:
- Journal of Bone & Mineral Research, 1994, v. 9, n. 1, p. 59, doi. 10.1002/jbmr.5650090109
- By:
- Publication type:
- Article
Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
- Published in:
- Journal of Bone & Mineral Research, 1992, v. 7, n. 9, p. 1093, doi. 10.1002/jbmr.5650070913
- By:
- Publication type:
- Article
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation.
- Published in:
- Nature Genetics, 2005, v. 37, n. 9, p. 945, doi. 10.1038/ng1614
- By:
- Publication type:
- Article
Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.
- Published in:
- Acta Orthopaedica, 2011, v. 82, n. 5, p. 628, doi. 10.3109/17453674.2011.625539
- By:
- Publication type:
- Article
Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats After Chronic Spinal Cord Injury.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts.
- Published in:
- 2017
- By:
- Publication type:
- Other
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 4, p. 834, doi. 10.1002/jbmr.2936
- By:
- Publication type:
- Article
Sclerostin Antibody Preserves the Morphology and Structure of Osteocytes and Blocks the Severe Skeletal Deterioration After Motor-Complete Spinal Cord Injury in Rats.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 7, p. 1482, doi. 10.1002/jbmr.2864
- By:
- Publication type:
- Article
Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap<sup>-/-</sup> Mice, a Model of Recessive Osteogenesis Imperfecta.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 5, p. 1030, doi. 10.1002/jbmr.2776
- By:
- Publication type:
- Article
Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats.
- Published in:
- Journal of Bone & Mineral Research, 2015, v. 30, n. 11, p. 1994, doi. 10.1002/jbmr.2549
- By:
- Publication type:
- Article
Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 6, p. 1424, doi. 10.1002/jbmr.2152
- By:
- Publication type:
- Article
Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
- Published in:
- Journal of Orthopaedic Research, 2014, v. 32, n. 8, p. 997, doi. 10.1002/jor.22636
- By:
- Publication type:
- Article
Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model.
- Published in:
- Journal of Orthopaedic Research, 2014, v. 32, n. 2, p. 197, doi. 10.1002/jor.22498
- By:
- Publication type:
- Article
Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats.
- Published in:
- Journal of Orthopaedic Research, 2012, v. 30, n. 10, p. 1541, doi. 10.1002/jor.22109
- By:
- Publication type:
- Article